在过去10余年中,已发现几种治疗方法对多发性骨髓瘤(MM)是有效的.长春新碱-阿霉素联合输注加地塞米松(DEX)间歇应用(VAD)在25%对标准方案耐药及大约45%复发病人中可明显减少肿瘤大小,但这一方案没能改善疗效或初诊病人的生存期。DEX单独应用对大约1/4耐药的MM病人是有效的。作者对未经治疗病人的大剂量DEX进行了 Several treatments have been found to be effective in multiple myeloma (MM) over the past decade or so.Vincinux-doxorubicin plus infusion plus dexamethasone (DEX) intermittent use (VAD) is effective at 25% Drug resistance and approximately 45% of recurrent patients can be significantly reduced tumor size, but this program failed to improve the efficacy or survival of newly diagnosed patients. DEX alone is effective for about 1/4 resistant MM patients. The authors conducted a large dose of DEX on untreated patients